Metraipolis › archive › dc_3783707bd3ff

CAR-T Cell Therapy for Autoimmune Kidney Diseases: Where Do We Stand Now? — Europe PMC PMID:41155362

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41155362
DOI
10.3390/ijms262010070
License (as archived)
solo-consultazione
Archived
2026-11-09T06:23:56.946Z
SHA-256 of the archived text
c9a365a1a5984d190c3cd42da8fa783cfafc51849dc5bae0ff813c99b21d69cc
Stable URL of this page
https://metraipolis.com/documento/dc_3783707bd3ff

How to cite

CAR-T Cell Therapy for Autoimmune Kidney Diseases: Where Do We Stand Now? — Europe PMC PMID:41155362 — Europe PMC (en), https://europepmc.org/article/MED/41155362 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3783707bd3ff (Metraipolis archive dc_3783707bd3ff, sha256 c9a365a1a5984d190c3cd42da8fa783cfafc51849dc5bae0ff813c99b21d69cc)
BibTeX
@misc{dc3783707bd3ff,
  title = {CAR-T Cell Therapy for Autoimmune Kidney Diseases: Where Do We Stand Now? — Europe PMC PMID:41155362},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41155362},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3783707bd3ff; sha256 c9a365a1a5984d190c3cd42da8fa783cfafc51849dc5bae0ff813c99b21d69cc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41155362. Agents can read the archived copy with the MCP tool read_document.